Source: Business Wire

Press Release: Avaxia Biologics : Research and Markets: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Pipeline Review 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/snl5xk/radiation) has announced the addition of the "Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug t

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Barbara S. Fox's photo - Founder & CEO of Avaxia Biologics

Founder & CEO

Barbara S. Fox

CEO Approval Rating

69/100

Read more